About Super Formulations
Super Formulations is a company based in Ujjain (India). It operates as a B2B. The company has 72 employees as of March 31, 2024. Super Formulations offers products and services including Aceclofenaco 100mg, Acedol-SP, Acetylsalicylic Acid Tablets, Aciclovir Cream, and BECLOWET – C. Super Formulations operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Ujjain, India
- Employees 72 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Super Formulations Private Limited
- Date of Incorporation 26 Jul, 2004
- Jurisdiction Ujjain, Madhya Pradesh, India
-
Annual Revenue
$14.47 M (USD)17.42as on Mar 31, 2024
-
Net Profit
$1.54 M (USD)494.08as on Mar 31, 2024
-
EBITDA
$2.29 M (USD)327.07as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
72
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Super Formulations
Super Formulations offers a comprehensive portfolio of products and services, including Aceclofenaco 100mg, Acedol-SP, Acetylsalicylic Acid Tablets, Aciclovir Cream, and BECLOWET – C.
Pharmaceutical drug for pain relief and inflammation.
Medication for specific health conditions like pain.
Aspirin tablets for pain, fever, and anti-inflammatory use.
Topical treatment for viral infections.
Pharmaceutical product for health applications.
Funding Insights of Super Formulations
Detailed funding history for Super Formulations
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Super Formulations
Investment portfolio details for Super Formulations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Super Formulations
Detailed financials for Super Formulations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Super Formulations Comparisons
Peer comparison for Super Formulations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Super Formulations
Super Formulations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Super Formulations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Super Formulations
Complete news archive for Super Formulations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Super Formulations
Super Formulations is headquartered in Ujjain, India. It is registered at Ujjain, Madhya Pradesh, India.
As of Mar 31, 2024, the latest employee count at Super Formulations is 72.
Annual revenue of Super Formulations is $14.47M as on Mar 31, 2024.
Superformulations is a pharmaceutical company based in Ujjain, India, specializing in manufacturing and marketing a variety of drugs and medicines. They supply products to local and global companies, including exports to countries like Honduras and Angola. With over 35 years of experience since 1984, they focus on precision, care, and adherence to industry standards in production and distribution.
Super Formulations's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Super Formulations offers Aceclofenaco 100mg, Acedol-SP, Acetylsalicylic Acid Tablets, Aciclovir Cream, and BECLOWET – C.